New research has demonstrated the effectiveness of a first-in-class oral, non-hormonal drug in increasing embryo implantation, pregnancy and live birth rates among infertile women who are undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
Humanaut Health Secures $8.7M to Expand Premium Longevity Clinics Nationwide
Humanaut Health senior leaders (from top left): Ernie Navarro, Tony Cheng, Nicholas Bernhardt-Lanier, Luke Pezet, Trey Owen, Jenny Espey, Tabor Pittman, Jim Donnelly, Amy Killen,
May 10, 2024